177 related articles for article (PubMed ID: 11266419)
1. Antimycobacterial activity of 1-deaza-7,8-dihydropteridine derivatives against Mycobacterium tuberculosis and Mycobacterium avium complex in vitro.
Suling WJ; Maddry JA
J Antimicrob Chemother; 2001 Apr; 47(4):451-4. PubMed ID: 11266419
[TBL] [Abstract][Full Text] [Related]
2. Antimycobacterial activities of 2,4-diamino-5-deazapteridine derivatives and effects on mycobacterial dihydrofolate reductase.
Suling WJ; Seitz LE; Pathak V; Westbrook L; Barrow EW; Zywno-Van-Ginkel S; Reynolds RC; Piper JR; Barrow WW
Antimicrob Agents Chemother; 2000 Oct; 44(10):2784-93. PubMed ID: 10991861
[TBL] [Abstract][Full Text] [Related]
3. Susceptibilities of Mycobacterium tuberculosis and Mycobacterium avium complex to lipophilic deazapteridine derivatives, inhibitors of dihydrofolate reductase.
Suling WJ; Reynolds RC; Barrow EW; Wilson LN; Piper JR; Barrow WW
J Antimicrob Chemother; 1998 Dec; 42(6):811-5. PubMed ID: 10052907
[TBL] [Abstract][Full Text] [Related]
4. New antifolate inhibitors for Mycobacterium avium.
Barrow EW; Suling WJ; Seitz LE; Reynolds RC; Barrow WW
Med Chem; 2006 Sep; 2(5):505-10. PubMed ID: 17017990
[TBL] [Abstract][Full Text] [Related]
5. Ring-substituted 8-hydroxyquinoline-2-carboxanilides as potential antimycobacterial agents.
Kos J; Zadrazilova I; Nevin E; Soral M; Gonec T; Kollar P; Oravec M; Coffey A; O'Mahony J; Liptaj T; Kralova K; Jampilek J
Bioorg Med Chem; 2015 Aug; 23(15):4188-4196. PubMed ID: 26183541
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antimycobacterial activity of 1,2,4-triazole 3-benzylsulfanyl derivatives.
Klimesová V; Zahajská L; Waisser K; Kaustová J; Möllmann U
Farmaco; 2004 Apr; 59(4):279-88. PubMed ID: 15081345
[TBL] [Abstract][Full Text] [Related]
7. Antimycobacterial activity of ionic fullerene derivatives.
Bosi S; Da Ros T; Castellano S; Banfi E; Prato M
Bioorg Med Chem Lett; 2000 May; 10(10):1043-5. PubMed ID: 10843212
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vitro antimycobacterial activity of novel 3-(1H-pyrrol-1-yl)-2-oxazolidinone analogues of PNU-100480.
Sbardella G; Mai A; Artico M; Loddo R; Setzu MG; La Colla P
Bioorg Med Chem Lett; 2004 Mar; 14(6):1537-41. PubMed ID: 15006398
[TBL] [Abstract][Full Text] [Related]
9. Interactions of 5-deazapteridine derivatives with Mycobacterium tuberculosis and with human dihydrofolate reductases.
da Cunha EF; de Castro Ramalho T; Bicca de Alencastro R; Maia ER
J Biomol Struct Dyn; 2004 Oct; 22(2):119-30. PubMed ID: 15317473
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antimycobacterial activity of pyrazine and quinoxaline derivatives.
Seitz LE; Suling WJ; Reynolds RC
J Med Chem; 2002 Dec; 45(25):5604-6. PubMed ID: 12459027
[TBL] [Abstract][Full Text] [Related]
11. Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium.
Collins L; Franzblau SG
Antimicrob Agents Chemother; 1997 May; 41(5):1004-9. PubMed ID: 9145860
[TBL] [Abstract][Full Text] [Related]
12. Thiacetazone: in vitro activity against Mycobacterium avium and M. tuberculosis.
Heifets LB; Lindholm-Levy PJ; Flory M
Tubercle; 1990 Dec; 71(4):287-91. PubMed ID: 1702564
[TBL] [Abstract][Full Text] [Related]
13. Quantitative structure-activity relationships for the in vitro antimycobacterial activity of pyrazinoic acid esters.
Bergmann KE; Cynamon MH; Welch JT
J Med Chem; 1996 Aug; 39(17):3394-400. PubMed ID: 8765523
[TBL] [Abstract][Full Text] [Related]
14. Growth inhibition of Mycobacterium bovis, Mycobacterium tuberculosis and Mycobacterium avium in vitro: effect of 1-beta-D-2'-arabinofuranosyl and 1-(2'-deoxy-2'-fluoro-beta-D-2'-ribofuranosyl) pyrimidine nucleoside analogs.
Johar M; Manning T; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R
J Med Chem; 2007 Jul; 50(15):3696-705. PubMed ID: 17602465
[TBL] [Abstract][Full Text] [Related]
15. Antimycobacterial evaluation and preliminary phytochemical investigation of selected medicinal plants traditionally used in Mozambique.
Luo X; Pires D; Aínsa JA; Gracia B; Mulhovo S; Duarte A; Anes E; Ferreira MJ
J Ethnopharmacol; 2011 Sep; 137(1):114-20. PubMed ID: 21571059
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro antimycobacterial activity of 2-methoxybenzanilides and their thioxo analogues.
Kozic J; Novotná E; Volková M; Stolaříková J; Trejtnar F; Vinšová J
Eur J Med Chem; 2012 Oct; 56():387-95. PubMed ID: 22907036
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by novel dideoxy nucleosides.
Rai D; Johar M; Srivastav NC; Manning T; Agrawal B; Kunimoto DY; Kumar R
J Med Chem; 2007 Sep; 50(19):4766-74. PubMed ID: 17696514
[TBL] [Abstract][Full Text] [Related]
18. Antimycobacterial evaluation of germacranolides.
Fischer NH; Lu T; Cantrell CL; Castañeda-Acosta J; Quijano L; Franzblau SG
Phytochemistry; 1998 Sep; 49(2):559-64. PubMed ID: 9747541
[TBL] [Abstract][Full Text] [Related]
19. Heterocyclic benzazole derivatives with antimycobacterial in vitro activity.
Kocí J; Klimesová V; Waisser K; Kaustová J; Dahse HM; Möllmann U
Bioorg Med Chem Lett; 2002 Nov; 12(22):3275-8. PubMed ID: 12392731
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antimycobacterial activity of some N1-[1-[3-aryl-1-(pyridin-2-, 3-, or 4-yl)-3-oxo]propyl]-2- pyridinecarboxamidrazones.
Mamolo MG; Falagiani V; Vio L; Banfi E
Farmaco; 1999; 54(11-12):761-7. PubMed ID: 10668176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
